塞夫特里亚克森的使用减少了与慢性病实验模型相关的血管化
Teresa Obrero Sojo1, Ma José Jiménez Moral2, Fátima Guerrero Pavón2
1Research Group: "Calcium metabolism. Vascular calcification", Maimonides Biomedical Research Institute of Cordoba (IMIBIC), University of Córdoba, Reina Sofia University Hospital, Córdoba, Spain.
概括
在慢性脏病模型中,使用 ceftriaxone 削弱肠道微生物群降低了酸盐水平和血管化. 这表明,向肠道细菌可能有助于管理慢性病患者的矿物质失衡和化.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 微生物学 微生物学
- 心血管研究研究心血管研究
背景情况:
- 肠道微生物群失调与全身炎症,慢性病 (CKD) 和血管化 (VC) 的恶化有关.
- 抗生素诱导的肠道微生物群枯竭对CKD中VC的影响尚不清楚.
研究的目的:
- 在CKD和VC的实验模型中调查肠道微生物群枯竭的作用.
- 评估抗生素塞夫特里亚克森对矿物代谢,功能和VC的影响.
主要方法:
- 在Wistar大鼠中建立了慢性和急性CKD和VC的实验模型.
- 在诱导CKD和VC之前,使用 ceftriaxone (ATB) 来消耗肠道微生物群.
- 分析的参数包括矿物代谢,功能,骨组织形态测量,VC,信号通路,尿素毒素和便微生物群.
主要成果:
- 抗生素治疗显著降低了血清酸盐水平,并减少了尿素毒素和VC.
- 没有观察到 ceftriaxone 治疗对骨周转的显著影响.
- 特定的细菌系 (Colidextribacter,Escherichia-Shigella) 与酸盐水平相关,并且被 ceftriaxone 降低.
结论:
- 使用 ceftriaxone 的微生物群枯竭有效降低了实验性CKD 中的高酸血症和血管化.
- 准肠道微生物群是一个潜在的治疗策略,用于管理矿物代谢障碍和CKD中的VC.
相关概念视频
01:30Urinary Tract Calculi III: Medical Management
307
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
307
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
301
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
301
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
434
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
434
01:11Renal Failure: Dose Adjustments
549
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
549
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
289
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
289
01:28Chronic Kidney Disease III: Interprofessional Care
561
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
561